Live Breaking News & Updates on Profit Share Territory

Stay updated with breaking news from Profit share territory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update

First quarter total revenue of $109 million, Crysvita® revenue of $83 million and Dojolvi® revenue of $16 million Reaffirmed 2024 expected total revenue guidance between $500 million to $530. ....

United States , Emild Kakkis , Daiichi Sankyo , Joshua Higa , Drug Administration , Contacts Ultragenyx Pharmaceutical Inc , Exchange Commission , American Academy Of Neurology Meeting , Ultragenyx Pharmaceutical Inc , Udall Foundation , Kyowa Kirin Co , Expansion Cohorts , Dose Escalation Cohort , Financial Data Tables , Financial Results , Months Ended March , Latin America , Profit Share Territory , Financial Data , Cash Used , North America , Osteogenesis Imperfecta , Annual American Academy , Dose Escalation Cohorts , Natural History , Reagan Udall Foundation ,